Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2012-02-06 07:30 |
VIVALIS : DÉCLARATION ACTIONS ET DROITS DE VOTE
|
French | 6.6 KB | ||
| 2012-01-24 17:40 |
VIVALIS announces a 112% rise in revenue for the full-year period ended Decembe…
|
English | 68.3 KB | ||
| 2012-01-24 17:40 |
VIVALIS annonce une hausse des revenus de 112 % en 2011
|
French | 73.6 KB | ||
| 2012-01-23 17:40 |
VIVALIS : Inauguration du nouveau laboratoire dédié à la plateforme VIVA|Screen…
|
French | 2.0 MB | ||
| 2012-01-23 17:40 |
VIVALIS: Opening of a new laboratory dedicated to the VIVA|Screen(TM) antibody …
|
English | 1.9 MB | ||
| 2012-01-17 17:40 |
VIVALIS et Sanofi Pasteur étendent leur contrat de collaboration et de licence …
|
French | 71.5 KB | ||
| 2012-01-17 17:40 |
VIVALIS and Sanofi Pasteur extend their 2010 collaboration and license contract
|
English | 94.1 KB | ||
| 2012-01-10 18:28 |
VIVALIS :ACTIONS ET DROITS DE VOTE DEC 2011
|
English | 7.3 KB | ||
| 2012-01-09 17:45 |
VIVALIS :BILAN SEMESTRIEL CONTRAT DE LIQUIDITÉ
|
English | 197.5 KB | ||
| 2012-01-04 17:41 |
VIVALIS announces its schedule for the publication of financial information for…
|
English | 73.3 KB | ||
| 2012-01-04 17:41 |
VIVALIS annonce son agenda des publications financières 2012
|
French | 85.5 KB | ||
| 2011-12-22 17:40 |
VIVALIS ANNOUNCES A NEW EB66® CELL LINE RESEARCH LICENSE AGREEMENT WITH A MAJOR…
|
English | 73.3 KB | ||
| 2011-12-22 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE AVEC UN DES AC…
|
French | 78.7 KB | ||
| 2011-12-01 18:32 |
VIVALIS : ACTIONS ET DROITS DE VOTE
|
French | 7.3 KB | ||
| 2011-11-07 17:40 |
VIVALIS : ACTIONS ET DROITS DE VOTE
|
English | 7.3 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
